Expand knowlegde on determinants of medicine use
Our focus lies on prevention and treatment of disease by medicines, including drugs and vaccines, considering effects on quality of life and costs, clinical management of drug therapy and drug safety, all explicitly as part of healthy ageing.
Emphasis is on pharmaceutical treatments through all stages of life from reproduction phase through phases of multi-factorial diseases and old age as well as primary prevention of diseases.
We aim to further expand scientific knowledge on determinants of medicine use, and on their effects in clinical practice on population and individual level.
Findings will support pharmaceutical decision-making from clinical drug development stage, regulatory approval, reimbursement to finally optimal medicine use. Ultimately, this will contribute to improved health-related quality of life of our ageing population and make pharmaceutical healthcare more efficient and sustainable.